Moderna, Inc.

Unlike other major vaccine providers such as Pfizer or Astra-Zeneca, Moderna has only one product commercially available – their COVID-19 vaccine. However, Moderna has existed since 2010 and has a large range of other vaccines and mRNA therapies undergoing clinical trials. Having been catapulted to the first rank of biopharmaceuticals by the pandemic in 2020 and taking in tens of billions of dollars in vaccine revenue, there is significant interest in what Moderna will produce next.

Founded by biologist Derrick Rossi and immunologist Timothy Springer, Moderna from its foundation was focused on the medical potential of mRNA therapies. RNA (Ribonucleic Acid) is a form of genetic code that controls gene expression and has a role in protein synthesis, alongside countless other functions. The m in mRNA stands for ‘messenger’, which are strands of RNA that provide the basic information for protein synthesis. Moderna develops synthetic mRNA which triggers the patient’s body to begin producing certain proteins - in the case of their vaccine, antibodies. Moderna believe this technology has a wide range of applications outside of coronavirus and are in the trial stages for a range of similar vaccines and therapies.

Moderna’s 2018 IPO was hotly anticipated and became the largest Biotech IPO to date. Moderna started trading on the NASDAQ exchange at $24 per share, valuing the company at $7.5 billion. At that time, of course, Moderna had no commercial products, but a great flair for raising money. Already the recipient of $2.6 billion in equity financing before its IPO, Moderna’s contract for the COVID-19 vaccine saw the share price briefly above $400 in early 2021. With over 200 million doses administered, some analysts were disappointed with the revenues produced by the vaccine, though they still amount to a profit of several billion dollars. Moderna has major institutional interest, with Baillie Gifford and venture capitalists Flagship Pioneering the largest shareholders. CEO Stéphane Bancel is also a major shareholder, owning around 9% of the company.

SaxotraderGO HERO

Invest in Moderna, Inc. stocks in SaxoTraderGO

Do you want more information about investing or investing in the Moderna, Inc. stock? Then open an account with Saxo Bank now. You will also receive technical analysis, expert insights, market news and much more.

SaxotraderGO HERO

See stock analyzes and key figures Moderna, Inc.

Get access to clear analyzes and key figures for the Moderna, Inc. stock. At Saxo Bank, you will find expert insights from our own SaxoStrats, view market analysts as well as technical analysis, all gathered in one place.

Before investing in individual stocks, it is recommended to make a thorough analysis. Investing carries risks, your investment can lose value.

Stocks illustration_769x385_v2

*The illustration is used as an example only. For the most up-to-date information on this instrument, existing customers should use the trading platform.

Gainers
Instrument
Visa Inc.
3V64:xetr . EUR
Deutsche Bank
DBK:xmil . EUR
Thomson Medical Group Ltd
A50:xses . SGD
Deutsche Bank AG
DBK:xetr . EUR
Pfizer Inc.
PFE:xnys . USD
Instrument

“Market movers” show you the biggest price fluctuations across selected markets. Data is delayed up to 30 minutes. See the full disclaimer for more information.

Invest in popular stocks, in addition to Moderna, Inc.

Invest in popular stocks, in addition to Moderna, Inc.

At Saxo Bank, you can trade over 19,000 stocks. The large selection allows you to find exactly what you need, from niche small-cap options to the well-known large companies with high market caps. See a selection of the most popular stocks you can invest in on our user-friendly platforms, SaxoTraderGO.

Find your next investment

Are you looking for inspiration? Our SaxoStrats provide daily analysis across asset classes including stocks that can help you identify your next opportunity. If you want to invest in a specific market trend, you can select stocks based on different themes. Use our Stock Screener to filter stocks by sector, market, investment theme and more.
Find our investment
Account-overview-front-desktop

Should our experts invest for you?

Do not have the time, knowledge or energy to make your own investments? So let our independent experts navigate the market and manage your investments for you.

Frequently asked questions about Moderna, Inc.

Find quick answers to your questions about trading Moderna, Inc. at Saxo Bank. We have gathered answers to the questions we most often get from new and existing customers.

To buy Moderna shares, log in to our platforms - SaxoInvestor, SaxoTraderGO or SaxoTraderPRO - and search for the ticker ‘MRNA’. If you don’t have an account, you can create one by clicking here.

Find the price of Moderna shares on your Saxo account by selecting the trade ticket, clicking on the ‘I’ icon and navigating to ‘Trading Rates’ to see costs. No account? No problem – just click here to open a Saxo account now.

Our platforms offer a range of different financial information to help you decide if Moderna is the right investment for you. You will find stock analysis, financial reports, and current and historical price charts on your account. You can open an account here.

Moderna does not pay a dividend to investors. Biotechnology companies often reinvest earnings back into the company for growth and expansion into new ventures.

You can check how Moderna shares have performed in the past by logging in to your trading platform account to see detailed price charts and historical financial data. If you don’t have an account, you can open one by clicking here.

Information on this page is not intended for investment advice or as an individual recommendation for trading. Reward to the author of this article was / is not related to his / her specific recommendation or views. Although Saxo Bank carefully collects and maintains these pages using reliable sources, Saxo Bank can not guarantee that this information is correct, complete or current. If you use this information without verification, it is at your own expense and risk. No rights can be inferred from the information on these pages. Investment involves risks. Your investment may be worth less. Read more information about the specific product risks on the product pages.

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900
Hellerup
Denmark

Contact Saxo

Select region

International
International

Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

This website can be accessed worldwide however the information on the website is related to Saxo Bank A/S and is not specific to any entity of Saxo Bank Group. All clients will directly engage with Saxo Bank A/S and all client agreements will be entered into with Saxo Bank A/S and thus governed by Danish Law.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.